This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Carol L. Wurzel, MD; Karen Halom, RN; Joseph G. Feldman, PhD; Lorry G. Rubin, MD

Am J Dis Child. 1988;142(5):536-540.

Abstract
• We retrospectively identified and prospectively followed up 62 patients with 78 venous-access catheters over a 30-month period (15 773 catheter-days) to compare infectious complications of Broviac-Hickman catheters (n=33) and totally implantable venous devices (n=45) in pediatric oncology patients. Demographic data and characteristics of catheter use were comparable for both groups. Significantly associated with the risk of a catheter-associated infection were (1) the percentage of time the patient was neutropenic and (2) a patient age of younger than 2 years. In the Broviac-Hickman catheter group, 14 catheter-associated infections occurred in 27% of patients using catheters for an infection rate of 0.21/100 catheter-days. In the implantable venous device group, 13 infections occurred in 24% of patients using catheters for an infection rate of 0.14/100 catheter-days. The relative risk of infection from Broviac-Hickman catheters compared with implantable venous devices was 1.5, which was not significant (95% confidence interval, 0.7 to 3.2). Thus, the incidence of infectious complications was comparable for both catheter types.

(AJDC 1988;142:536-540)

Author Affiliations
From the Division of Infectious Diseases (Drs Wurzel and Rubin), Department of Pediatrics (Ms Halom), Schneider Children's Hospital of Long Island Jewish Medical Center, New Hyde Park, NY; the Health Sciences Center, State University of New York at Stony Brook (Dr Rubin); and the Health Sciences Center and Department of Preventive Medicine, State University of New York at Brooklyn (Dr Feldman).

Footnotes
Accepted for publication Feb 1, 1988.

Reprint requests to Division of Infectious Diseases, Schneider Children's Hospital of Long Island Jewish Medical Center, New Hyde Park, NY 11042 (Dr Rubin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Catheter-Related Deep Venous Thrombosis and Other Catheter Complications in Children With Cancer
Journeycake and Buchanan
JCO 2006;24:4575-4580.
ABSTRACT | FULL TEXT  

Central Venous Lines in Children With Lesser Risk Acute Lymphoblastic Leukemia: Optimal Type and Timing of Placement
McLean et al.
JCO 2005;23:3024-3029.
ABSTRACT | FULL TEXT  

Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients
Munck et al.
Eur Respir J 2004;23:430-434.
ABSTRACT | FULL TEXT  

Catheter Design Influences Recurrence of Catheter-Related Bloodstream Infection in Children With Cancer
Flynn et al.
JCO 2003;21:3520-3525.
ABSTRACT | FULL TEXT  

Stability of Antibiotics Used for Antibiotic-Lock Treatment of Infections of Implantable Venous Devices (Ports)
Anthony and Rubin
Antimicrob. Agents Chemother. 1999;43:2074-2076.
ABSTRACT | FULL TEXT  

Catheter Infections: Diagnosis, Etiology, Treatment, and Prevention
Krzywda et al.
Nutr Clin Pract 1999;14:178-190.
ABSTRACT  

Lesson of the Week: Retention of drugs in venous access port chamber: a note of caution
Ben-Arush and Berant
BMJ 1996;312:496-497.
FULL TEXT  

Clinical Predictors of Catheter Use Following Implantation of Intravenous Access Devices in Cystic Fibrosis Patients
Homnick et al.
CLIN PEDIATR 1993;32:114-117.
 

The Use of Venous Access Devices in Pediatric Oncology Nursing Practice
Keegan-Wells and Stewart
Journal of Pediatric Oncology Nursing 1992;9:159-169.
ABSTRACT  

An Investigation of the Safety of the Blood Reinfusion Step Used With Tunneled Venous Access Devices in Children With Cancer
Hinds et al.
Journal of Pediatric Oncology Nursing 1991;8:159-164.
ABSTRACT